Pegylated liposomal doxorubicin as a chemotherapeutic agent for treatment of canine transmissible venereal tumor in murine models

Journal of Veterinary Medical Science

Volumn 67, Issue 11, 2005, Pages 1133-1139

  Stettner, Noa ^a   Brenner, Ori ^a   Eilam, Raya ^a   Harmelin, Alon ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Animal model; Apoptosis; Canine transmissible venereal tumor; Chemotherapy; Doxil

Indexed keywords

DOXORUBICIN; DRUG DERIVATIVE; MACROGOL DERIVATIVE;

ANALYSIS OF VARIANCE; ANIMAL; ANIMAL DISEASE; ANIMAL VENEREAL TUMOR; ARTICLE; COMPARATIVE STUDY; DOG; DOG DISEASE; IMMUNOHISTOCHEMISTRY; MOUSE; MOUSE MUTANT; NICK END LABELING; NONOBESE DIABETIC MOUSE; SPECIES DIFFERENCE; TIME; XENOGRAFT;

ANALYSIS OF VARIANCE; ANIMALS; DOG DISEASES; DOGS; DOXORUBICIN; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MICE; MICE, INBRED NOD; MICE, SCID; POLYETHYLENE GLYCOLS; SPECIES SPECIFICITY; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS; VENEREAL TUMORS, VETERINARY;

ANIMALIA; MURINAE;

EID: 28744452244     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.67.1133     Document Type: Article

References (29)

1. Aiello, S.E. 1998. Transmissible canine venereal tumor, pp. 683-684. In: The Merck Veterinary Manual. 8th ed., Merck & Co., New Jersey.
2. Cohen, D. 1985. The canine transmissible venereal tumor: a unique result of tumor progression. Adv. Cancer Res. 43: 75-112.
3. Das, U. and Das, A.K. 2000. Review of canine transmissible venereal sarcoma. Vet. Res. Commun. 24: 545-556.
4. Gabizon, A. and Martin, F. 1997. Polyethylene glycol-coated (pegylated) liposomal doxorubicin- Rationale for use in solid tumors. Drugs 54 (Suppl. 4): 15-21.
5. Gabizon, A., Isacson, R., Libson, E., Kaufman, B., Uziely, B., Catane, R., Ben-Dor, C.G., Rabello, E., Cass, Y., Peretz, T., Sulkes, A., Chisin, R. and Barenholz, Y. 1994. Clinical studies of liposome-encapsulated doxorubicin. Acta Oncol. 33: 779-786.
6. Gabizon, A., Shmeeda, H. and Barenholz, Y. 2003. Pharmacokinetics of pegylated liposomal doxorubicin. Review of animal and human studies. Clin. Pharmacokinet. 42: 419-436.
7. Gabizon, A. 2001. Pegylated liposomal doxorubicin: Metamorphosis of an old drug into a new form of chemothetapy. Cancer Invest. 19: 424-436.
8. Gabizon, A.A., Pappo, O., Goren, D., Chemla, M., Tzemach, D. and Horowitz, A.T. 1993. Preclinical studies with doxorubicin encapsulated in polyethyleneglycol-coated liposomes. J. Liposome Res. 3: 517-528.
9. Gewirtz, D.A. 1999. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem. Pharmacol. 7: 727-741.
10. Gonzalez, C.M., Griffey, S.M., Naydan, D.K., Flores, E., Cepeda, R., Cattaneo, G. and Madewell, B.R. 2000. Canine transmissible venereal tumour: a morphological and immunohistochemical study of 11 tumours in growth phase and during regression after chemotherapy. J. Comp. Pathol. 122: 241-248.
11. Harmelin, A., Pinthus, J.H., Friedmann-Morvinski, D., Kaufman, K. and Brenner, O. 2002. Lack of MHC expression and retention of ultrastructural characteristics by xenograft transmissible venereal tumor cells in SCID mice Vet. Immunol. Immunopathol. 86: 245-249.
12. Harmelin, A., Pinthus, J.H., Katzir, N., Kapon, A., Volcani, Y., Amariglio, E.N. and Rehavi, G. 2001. Use of a marine xenograft model for canine transmissible venereal tumor. Am. J. Vet. Res. 62: 907-911.
13. Harrison, M., Tomlinson, D. and Stewart, S. 1995. Liposomal-Entrapped Doxorubicin: An active agent in AIDS-related Kaposi's sarcoma. J. Clin. Oncol. 13: 914-919.
14. Hayes, H.M. Jr, Biggar, R.J., Pickle, L.W. and Hoover, R. 1983. Canine transmissible venereal tumor: A model for Kaposi's sarcoma. Am. J. Epidemiol. 117: 108-109.
15. Hill, D.L., Yang, T.J. and Wachtel, A. 1984. Canine transmissible venereal sarcoma: Tumor cell and infiltrating leukocyte ultrastructure at different growth stages. Vet. Pathol. 21: 39-45.
16. Holmes, J.M. 1981. Measurement of the rate of death of canine transmissible venereal tumour cells transplanted into dogs and nude mice. Res. Vet. Sci. 30: 248-250.
17. Hsiao, Y.W., Liao, K.W., Hung, S.W. and Chu, R.M. 2002. Effect of tumor infiltrating lymphocytes on the expretion of MHC molecules in canine transmissible venereal tumor cells. Vet. Immunol. Immunopathol. 87: 19-27.
18. Liano, K.W., Hung, S.W., Hsiao, Y.W., Bennett, M. and Chu, R.M. 2003. Canine transmissible venereal tumor cell depletion of B lymphocytes: molecule(s) specifically toxic for B cells. Vet. Immunol. Immunopathol. 92: 149-162.
19. Marchal, T., Chabanne, L., Kaplanski, C., Rigal, D. and Magnol, J.P. 1997. Immunophenotype of the canine transmissible venereal tumor. Vet. Immunol. Immunopathol. 57: 1-11.
20. Mizutani, H., Tada-Oikawa, S., Hiraku, Y., Kojima, M. and Kawanishi, S. 2005. Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide. Life Sci. 76: 1439-1453.
21. Mukaratirwa, S. and Gruys, E. 2003. Canine transmissible venereal tumor: cytogenetic origin, immunophenotype, and immunobiology. A review. Vet. Q. 25: 101-111.
22. National Research Council. 1996. Guide for the Care and Use of Laboratory Animals. Washington, D.C. National Academy Press.
23. Nomura, T., Takahama, Y., Hongyo, T., Takatera, H., Inohara, H., Fukushima, H., Ono, S. and Hamaoka, T. 1991. Rapid growth and spontaneous metastasis of human germinal tumors ectopically transplanted into scid (severe combined immunodeficiency) and scid-nudestreaker mice. Jpn J. Cancer Res. 82: 701-709.
24. Perez, J., Day, M.J. and Mozos, E. 1998. Immunohistochemical study of the local inflammatory infiltrate in spontaneous canine transmissible venereal tumor at different stages of growth. Vet Immunol. Immunopathol. 64: 133-147.
25. Pinthus, J.H., Waks, T., Schindler, D.G., Harmelin, A., Said, J.W., Belldegrum, A., Ramon, J. and Eshhar, Z. 2000. WISH-PC2: A unique xenograft model of human prostatic small cell carcinoma. Cancer Res. 60: 6563-6567.
26. Rechavi, G., Katzir, N. and Ramot, B. 1991. Kaposi's sarcoma among AIDS patients: Transmissible venereal tumor by cell engrafment? Med. Hypotheses 34: 338-341.
27. Vail, D.M., Kravis, L.D., Cooley, A.J., Chun, R. and MacEwen, E.G. 1997. Preclinical trial of doxorubicin entrapped in sterically stabilized liposomes in dogs with spontaneously arising malignant tumors. Cancer Chemother. Pharmacol. 39: 410-416.
28. Working, P.K. and Dayan, A.D. 1996. Pharmacological-toxicological expert report. CAELYX™. (Stealth® liposomal doxorubicin HCl). Hum Exp. Toxicol. 15: 751-785.
29. Yang, T.J. and Jones, J.B. 1973. Canine transmissible venereal sarcoma. Transplantation studies in neonatal and adult dogs. J. Natl Cancer Inst. 51: 1915-1918.